Cognitive-enhancing effects of a polyphenols-rich extract from fruits without changes in neuropathology in an animal model of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 55, Issue 1, 2016, Pages 115-135

  Dal Pan, Alexandre ^a,b,c   Dudonné, Stéphanie ^b   Bourassa, Philippe ^a,b,c   Bourdoulous, Morgane ^a   Tremblay, Cyntia ^a   Desjardins, Yves ^b   Calon, Frédéric ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c NutriNeuro Bordeaux University   (France)

Author keywords

3xTg AD; age related cognitive decline; Alzheimer's disease; polyphenols

Indexed keywords

AMYLOID BETA PROTEIN; BLUEBERRY EXTRACT; DIHYDROXYPHENYL VALEROLACTONE; DRUG METABOLITE; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; VITIS VINIFERA EXTRACT; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; BRAIN DERIVED NEUROTROPHIC FACTOR; MAPT PROTEIN, HUMAN; NOOTROPIC AGENT; PLANT EXTRACT; POLYPHENOL; PRESENILIN 1; PSEN1 PROTEIN, HUMAN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FRUIT; MEMORY; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; BRAIN; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; RECOGNITION; VACCINIUM; VITIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLUEBERRY PLANTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUIT; HUMANS; MALE; MICE, TRANSGENIC; NOOTROPIC AGENTS; PLANT EXTRACTS; POLYPHENOLS; PRESENILIN-1; RECOGNITION (PSYCHOLOGY); TAU PROTEINS; VITIS;

EID: 84994663338     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160281     Document Type: Article

References (91)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer?s disease. Lancet 377, 1019-1031.
2. Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, Plassman BL, Kukull WA (2011) National estimates of the prevalence of Alzheimer?s disease in the United States. Alzheimers Dement 7, 61-73.
3. Wimo A, Jönsson L, Bond J, Prince M, Winblad B (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9, 1-11.e13.
4. Cummings JL (2004) Alzheimer?s disease. N Engl J Med 351, 56-67.
5. Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, Calon F (2007) Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer?s disease. J Alzheimers Dis 12, 377-390.
6. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J Neuropathol Exp Neurol 71, 362-381.
7. Montine TJ, Monsell SE, Beach TG, Bigio EH, Yunqi B, Cairns NJ, Frosch M, Henriksen J, Julia K, Kukull WA, Lee EB, Nelson PT, Schantz AM, Schneider JA, Sonnen JA, Trojanowski JQ, Vinters HV, Zhou XH, Hyman BT (2016) Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer?s disease. Alzheimers Dement 12, 164-169.
8. LeBlanc AC (2005) The role of apoptotic pathways in Alzheimer?s disease neurodegeneration and cell death. Curr Alzheimer Res 2, 389-402.
9. Cummings J, Morstorf T, Zhong K (2014) Alzheimer?s disease drug-development pipeline: Few candidates, frequent failures. Alzheimers Res Ther 6, 37.
10. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer?s disease: Clinical trials and drug development. Lancet Neurol 9, 702-716.
11. Snyder PJ, Kahle-Wrobleski K, Brannan S, Miller DS, Schindler RJ, DeSanti S, Ryan JM, Morrison G, Grundman M, Chandler J, Caselli RJ, Isaac M, Bain L, Carrillo MC (2014) Assessing cognition and function in Alzheimer?s disease clinical trials: Do we have the right tools? Alzheimers Dement 10, 853-860.
12. De Strooper B (2014) Lessons from a failed gammasecretase Alzheimer trial. Cell 159, 721-726.
13. Calon F (2011) Omega-3 polyunsaturated fatty acids in Alzheimer?s disease: Key questions and partial answers. Curr Alzheimer Res 8, 470-478.
14. Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q, Harris-White ME, Frautschy SA (2005) Prevention of Alzheimer?s disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol Aging 26(Suppl 1), 133-136.
15. Swaminathan A, Jicha GA (2014) Nutrition and prevention of Alzheimer?s dementia. Front Aging Neurosci 6, 282.
16. Vauzour D (2014) Effect of flavonoids on learning, memory and neurocognitive performance: Relevance and potential implications for Alzheimer?s disease pathophysiology. J Sci Food Agric 94, 1042-1056.
17. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: Food sources and bioavailability. Am J Clin Nutr 79, 727-747.
18. Ferruzzi MG, Lobo JK, Janle EM, Cooper B, Simon JE, Wu Q-L, Welch C, Ho L, Weaver C, Pasinetti GM (2009) Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: Implications for treatment in Alzheimer?s disease. J Alzheimers Dis 18, 113-124.
19. Krikorian R, Boespflug EL, Fleck DE, Stein AL, Wightman JD, Shidler MD, Sadat-Hossieny S (2012) Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem 60, 5736-5742.
20. Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 3996-4000.
21. Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, Raffaele A, Ferri L, Bocale R, Lechiara MC, Marini C, Ferri C (2012) Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study. Hypertension 60, 794-801.
22. Joseph JA, Shukitt-Hale B, Willis LM (2009) Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr 139, 1813S-1817S.
23. Sun A, Wang Q, Simonyi A, Sun G (2008) Botanical phenolics and brain health. Neuromolecular Med 10, 259-274.
24. Devore EE, Kang JH, Breteler MMB, Grodstein F (2012) Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol 72, 135-143.
25. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357-363.
26. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues J, Barberger-Gateau P (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165, 1364-1371.
27. Cimini A, Gentile R, D?Angelo B, Benedetti E, Cristiano L, Avantaggiati ML, Giordano A, Ferri C, Desideri G (2013) Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer?s disease model by modulating BDNF signaling pathway. J Cell Biochem 114, 2209-2220.
28. Vauzour D (2012) Dietary polyphenols as modulators of brain functions: Biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev 2012, 914273.
29. Spencer JPE, Vauzour D, Rendeiro C (2009) Flavonoids and cognition: The molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys 492, 1-9.
30. Spencer J (2009) Flavonoids and brain health: Multiple effects underpinned by common mechanisms. Genes Nutr 4, 243-250.
31. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent A-oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer?s disease. J Neurosci 28, 6388-6392.
32. Wang J, Santa-Maria I, Ho L, Ksiezak-Reding H, Ono K, Teplow DB, Pasinetti GM (2010) Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer?s disease. J Alzheimers Dis 22, 653-661.
33. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153-162.
34. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-Transgenic model of Alzheimer?s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
35. Arsenault D, Dal-Pan A, Tremblay C, Bennett DA, Guitton MJ, DeKoninck Y, Tonegawa S, Calon F (2013) PAKinactivation impairs social recognition in 3xTg-AD mice without increasing brain deposition of tau and A-. J Neurosci 33, 10729-10740.
36. Vandal M, White PJ, Chevrier G, Tremblay C, St-Amour I, Planel E, Marette A, Calon F (2015) Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer?s disease. FASEB J 29, 4273-4284.
37. Julien C, Tremblay C, Phivilay A, Berthiaume L, Emond V, Julien P, Calon F (2010) High-fat diet aggravates amyloidbeta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 31, 1516-1531.
38. Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, De Koninck Y, Calon F (2012) Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer?s disease. PLoS One 7, e46111.
39. Vandal M, White PJ, Tremblay C, St-Amour I, Chevrier G, Emond V, Lefrancois D, Virgili J, Planel E, Giguere Y, Marette A, Calon F (2014) Insulin reverses the high-fat dietinduced increase in brain Abeta and improves memory in an animal model of Alzheimer disease. Diabetes 63, 4291-4301.
40. Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M (2014) Advances in the prevention of Alzheimer?s disease and dementia. J Intern Med 275, 229-250.
41. Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jonsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H (2016) Defeating Alzheimer?s disease and other dementias: A priority for European science and society. Lancet Neurol 15, 455-532.
42. Pasinetti GM, Eberstein JA (2008) Metabolic syndrome and the role of dietary lifestyles in Alzheimer?s disease. J Neurochem 106, 1503-1514.
43. Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho L, Fraser P, Westaway D, Hyslop PS, Martins RN, Buxbaum JD, Pasinetti GM, Dickstein DL, Hof PR, Ehrlich ME, Gandy S (2009) Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer?s amyloid pathology. Mol Neurodegener 4, 40.
44. Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E (2012) Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer?s disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res 234, 334-342.
45. Arsenault D, Julien C, Tremblay C, Calon F (2011) DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One 6, e17397.
46. St-Amour I, Pare I, Tremblay C, Coulombe K, Bazin R, Calon F (2014) IVIg protects the 3xTg-AD mouse model of Alzheimer?s disease from memory deficit and Abeta pathology. J Neuroinflammation 11, 54.
47. Latapy C, Rioux V, Guitton MJ, Beaulieu JM (2012) Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos Trans R Soc Lond B Biol Sci 367, 2460-2474.
48. Vandal M, White PJ, Tournissac M, Tremblay C, St-Amour I, Drouin-Ouellet J, Bousquet M, Traversy MT, Planel E, Marette A, Calon F (2016) Impaired thermoregulation and beneficial effects of thermoneutrality in the 3xTg-AD model of Alzheimer?s disease. Neurobiol Aging 43, 47-57.
49. Bengoetxea X, Rodriguez-Perdigon M, Ramirez MJ (2015) Object recognition test for studying cognitive impairments in animal models of Alzheimer?s disease. Front Biosci (Schol Ed) 7, 10-29.
50. Lebbadi M, Julien C, Phivilay A, Tremblay C, Emond V, Kang JX, Calon F (2011) Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer?s disease. J Alzheimers Dis 27, 853-869.
51. Antunes M, Biala G (2012) The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cogn Process 13, 93-110.
52. Tremblay C, St-Amour I, Schneider J, Bennett D, Calon F (2011) Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 70, 788-798.
53. Dudonné S, Dubé P, Pilon G, Marette A, Jacques H, Weisnagel J, Desjardins Y (2014) Modulation of strawberry/cranberry phenolic compounds glucuronidation by co-supplementation with onion: Characterization of phenolic metabolites in rat plasma using an optimized-SPE-UHPLC-MS/MS method. J Agric Food Chem 62, 3244-3256.
54. Horowitz P, Patterson K, Guillozet-Bongaarts A, Reynolds M, Carroll C, Weintraub S, Bennett D, Cryns V, Berry R, Binder L (2004) Early N-Terminal changes and caspase-6 cleavage of tau in Alzheimer?s disease. J Neurosci 24, 7895-7902.
55. Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer?s disease. J Alzheimers Dis 5, 65-77.
56. Bevins RA, Besheer J (2006) Object recognition in rats and mice: A one-Trial non-matching-To-sample learning task to study ?recognition memory?. Nat Protoc 1, 1306-1311.
57. Lu J, Wu D-M, Zheng Y-L, Hu B, Zhang Z-F, Shan Q, Zheng Z-H, Liu C-M, Wang Y-J (2010) Quercetin activates AMP-Activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol 222, 199-212.
58. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM (2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer?s disease. FASEB J 20, 2313-2320.
59. Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, Teplow D, Humala N, Cheng A, Percival SS, Ferruzzi M, Janle E, Dickstein DL, Pasinetti GM (2009) Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer?s disease-Type neuropathology and cognitive deterioration. J Alzheimers Dis 16, 59-72.
60. Pitozzi V, Jacomelli M, Catelan D, Servili M, Taticchi A, Biggeri A, Dolara P, Giovannelli L (2012) Long-Term dietary extra-virgin olive oil rich in polyphenols reverses age-related dysfunctions in motor coordination and contextual memory in mice: Role of oxidative stress. Rejuvenation Res 15, 601-612.
61. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103, 1024-1029.
62. Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, Whiteman M, Spencer JPE (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295-305.
63. Abd El Mohsen MM, Kuhnle G, Rechner AR, Schroeter H, Rose S, Jenner P, Rice-Evans CA (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693-1702.
64. Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SK, Moore KP, Rice-Evans CA (2004) Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic Biol Med 36, 212-225.
65. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216, 92-103.
66. Wolf AB, Braden BB, Bimonte-Nelson H, Kusne Y, Young N, Engler-Chiurazzi E, Garcia AN, Walker DG, Moses GS, Tran H, LaFerla F, Lue L, Emerson Lombardo N, Valla J (2012) Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sexspecificity in response to Alzheimer?s disease intervention. J Alzheimers Dis 32, 217-232.
67. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in beta-Amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure. Brain Res 1366, 233-245.
68. Santa-Maria I, Diaz-Ruiz C, Ksiezak-Reding H, Chen A, Ho L, Wang J, Pasinetti GM (2012) GSPE interferes with tau aggregation in vivo: Implication for treating tauopathy. Neurobiol Aging 33, 2072-2081.
69. Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V, Calon F (2008) Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology. J Neurosci Res 86, 2292-2302.
70. Ivanov A, Esclapez M, Ferhat L (2009) Role of drebrin A in dendritic spine plasticity and synaptic function: Implications in neurological disorders. Commun Integr Biol 2, 268-270.
71. Varamini B, Sikalidis AK, Bradford KL (2014) Resveratrol increases cerebral glycogen synthase kinase phosphorylation as well as protein levels of drebrin and transthyretin in mice: An exploratory study. Int J Food Sci Nutr 65, 89-96.
72. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller F-J, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106, 13594-13599.
73. Zhang W, Wang P-J, Sha H-Y, Ni J, Li M-H, Gu G-J (2014) Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer?s disease. Mol Neurobiol 50, 423-437.
74. Yuede CM, Lee H, Restivo JL, Davis TA, Hettinger JC, Wallace CE, Young KL, Hayne MR, Bu G, Li CZ, Cirrito JR (2016) Rapid in vivo measurement of beta-Amyloid reveals biphasic clearance kinetics in an Alzheimer?s mouse model. J Exp Med 213, 677-685.
75. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12, 856-861.
76. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342, 373-377.
77. Kazim SF, Blanchard J, Dai C-L, Tung Y-C, LaFerla FM, Iqbal I-G, Iqbal K (2014) Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer?s disease. Neurobiol Dis 71, 110-130.
78. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH (2008) BDNF is essential to promote persistence of long-Term memory storage. Proc Natl Acad Sci U S A 105, 2711-2716.
79. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD (2002) From acquisition to consolidation: On the role of brain-derived neurotrophic factor signaling in hippocampaldependent learning. Learn Mem 9, 224-237.
80. Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM (2002) BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 114, 795-805.
81. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung W-H, Hempstead BL, Lu B (2004) Cleavage of pro BDNF by tPA/plasmin is essential for long-Term hippocampal plasticity. Science 306, 487-491.
82. Castello NA, Green KN, LaFerla FM (2012) Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Abeta or tau pathology. PLoS One 7, e39566.
83. Shin M-K, Kim H-G, Baek S-H, Jung W-R, Park D-I, Park J-S, Jo D-G, Kim K-L (2014) Neuropep-1 ameliorates learning and memory deficits in an Alzheimer?s disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Neurobiol Aging 35, 990-1001.
84. Forlenza OV, Teixeira AL, Miranda AS, Barbosa IG, Talib LL, Diniz BS, Gattaz WF (2015) Decreased neurotrophic support is associated with cognitive decline in non-demented subjects. J Alzheimers Dis 46, 423-429.
85. Levites Y, Amit T, Youdim MBH, Mandel S (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277, 30574-30580.
86. Ito H, Sun X-L, Watanabe M, Okamoto M, Hatano T (2008) Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci Biotechnol Biochem 72, 885-888.
87. Reznichenko L, Amit T, Youdim MBH, Mandel S (2005) Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-Term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 1157-1167.
88. Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O (2006) Long-Term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 136, 1043-1047.
89. Ramirez MR, Izquierdo I, Raseira MdCB, Zuanazzi JA, Barros D, Henriques AT (2005) Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52, 457-462.
90. Maher P, Akaishi T, Abe K (2006) Flavonoid fisetin promotes ERK-dependent long-Term potentiation and enhances memory. Proc Natl Acad Sci U S A 103, 16568-16573.
91. Rendeiro C, Vauzour D, Rattray M, Waffo-Téguo P, Mérillon JM, Butler LT, Williams CM, Spencer JPE (2013) Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One 8, e63535.